drugset / Trial / NCT01095640

Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel

NCT01095640

Completed 1159 enrolled Actavis Mid-Atlantic LLC
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Marketed by Galderma Laboratories, L.P., Differin® (adapalene 0.3% topical gel) is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of adapalene 0.3% topical gel and the current study is designed to evaluate the safety and efficacy of this formulation.

Timeline

Start
2009-03
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Adapalene Other / unclassified 0.3 % Topical

Indications